Mckesson Corporation Exact Sciences Corporation

Mckesson Corporation Exact Sciences Corporation

Vote Summary Report Reporting Period: 07/01/2018 to 06/30/2019 Institution Account(s): TD Health Sciences Fund Page 1 of 94 McKesson Corporation Meeting Date: 07/25/2018 Country: USA Primary Security ID: 58155Q103 Record Date: 05/31/2018 Meeting Type: Annual Ticker: MCK Primary CUSIP: 58155Q103 Primary ISIN: US58155Q1031 Primary SEDOL: 2378534 Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 1a Elect Director N. Anthony Coles Mgmt Yes For For No 1b Elect Director John H. Hammergren Mgmt Yes For For No 1c Elect Director M. Christine Jacobs Mgmt Yes For For No 1d Elect Director Donald R. Knauss Mgmt Yes For For No 1e Elect Director Marie L. Knowles Mgmt Yes For For No 1f Elect Director Bradley E. Lerman Mgmt Yes For For No 1g Elect Director Edward A. Mueller Mgmt Yes For For No 1h Elect Director Susan R. Salka Mgmt Yes For For No 2 Ratify Deloitte & Touche LLP as Auditors Mgmt Yes For For No 3 Advisory Vote to Ratify Named Executive Mgmt Yes For For No Officers' Compensation 4 Report on Lobbying Payments and Policy SH Yes Against Against No 5 Pro-rata Vesting of Equity Awards SH Yes Against Against No 6 Use GAAP for Executive Compensation SH Yes Against Against No Metrics 7 Reduce Ownership Threshold for SH Yes Against Against No Shareholders to Call Special Meeting Exact Sciences Corporation Meeting Date: 07/26/2018 Country: USA Primary Security ID: 30063P105 Record Date: 05/31/2018 Meeting Type: Annual Ticker: EXAS Primary CUSIP: 30063P105 Primary ISIN: US30063P1057 Primary SEDOL: 2719951 Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 1.1 Elect Director Thomas D. Carey Mgmt Yes For Withhold Yes 1.2 Elect Director Daniel J. Levangie Mgmt Yes For Withhold Yes 1.3 Elect Director Michael S. Wyzga Mgmt Yes For Withhold Yes 2 Ratify BDO USA, LLP as Auditors Mgmt Yes For For No Vote Summary Report Reporting Period: 07/01/2018 to 06/30/2019 Institution Account(s): TD Health Sciences Fund Page 2 of 94 Exact Sciences Corporation Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 3 Advisory Vote to Ratify Named Executive Mgmt Yes For For No Officers' Compensation Jazz Pharmaceuticals plc Meeting Date: 08/02/2018 Country: Ireland Primary Security ID: G50871105 Record Date: 06/06/2018 Meeting Type: Annual Ticker: JAZZ Primary CUSIP: 472147107 Primary ISIN: IE00B4Q5ZN47 Primary SEDOL: B4Q5ZN4 Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 1a Elect Director Peter Gray Mgmt Yes For For No 1b Elect Director Kenneth W. O'Keefe Mgmt Yes For For No 1c Elect Director Elmar Schnee Mgmt Yes For For No 1d Elect Director Catherine A. Sohn Mgmt Yes For For No 2 Approve KPMG, Dublin as Auditors and Mgmt Yes For For No Authorize Board to Fix Their Remuneration 3 Advisory Vote to Ratify Named Executive Mgmt Yes For For No Officers' Compensation 4 Advisory Vote on Say on Pay Frequency Mgmt Yes One Year One Year No WAVE Life Sciences Ltd. Meeting Date: 08/07/2018 Country: Singapore Primary Security ID: Y95308105 Record Date: 06/22/2018 Meeting Type: Annual Ticker: WVE Primary CUSIP: N/A Primary ISIN: SG9999014716 Primary SEDOL: BYZG9R0 Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 1a Elect Director Paul B. Bolno Mgmt Yes For For No 1b Elect Director Christian O. Henry Mgmt Yes For Against Yes 1c Elect Director Peter Kolchinsky Mgmt Yes For For No 1d Elect Director Koji Miura Mgmt Yes For Against Yes 1e Elect Director Adrian Rawcliffe Mgmt Yes For Against Yes 1f Elect Director Ken Takanashi Mgmt Yes For Against Yes 1g Elect Director Gregory L. Verdine Mgmt Yes For For No Vote Summary Report Reporting Period: 07/01/2018 to 06/30/2019 Institution Account(s): TD Health Sciences Fund Page 3 of 94 WAVE Life Sciences Ltd. Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 2 Approve KPMG LLP as Auditors and Authorize Mgmt Yes For For No Audit Committee to Fix Their Remuneration 3 Approve Non-Employee Directors' Mgmt Yes For For No Compensation 4 Approve Issuance of Equity or Equity-Linked Mgmt Yes For For No Securities without Preemptive Rights HTG Molecular Diagnostics, Inc. Meeting Date: 08/15/2018 Country: USA Primary Security ID: 40434H104 Record Date: 06/18/2018 Meeting Type: Annual Ticker: HTGM Primary CUSIP: 40434H104 Primary ISIN: US40434H1041 Primary SEDOL: BXB3N09 Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 1.1 Elect Director Michelle R. Griffin Mgmt Yes For For No 1.2 Elect Director Ann F. Hanham Mgmt Yes For For No 1.3 Elect Director Timothy (TJ) B. Johnson Mgmt Yes For For No 2 Ratify BDO USA, LLP as Auditors Mgmt Yes For For No Cigna Corp. Meeting Date: 08/24/2018 Country: USA Primary Security ID: 125509109 Record Date: 07/10/2018 Meeting Type: Special Ticker: CI Primary CUSIP: 125509109 Primary ISIN: US1255091092 Primary SEDOL: 2196479 Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 1 Approve Merger Agreement Mgmt Yes For For No 2 Adjourn Meeting Mgmt Yes For Against Yes Express Scripts Holding Co. Meeting Date: 08/24/2018 Country: USA Primary Security ID: 30219G108 Record Date: 07/12/2018 Meeting Type: Special Ticker: ESRX Primary CUSIP: 30219G108 Primary ISIN: US30219G1085 Primary SEDOL: B7QQYV9 Vote Summary Report Reporting Period: 07/01/2018 to 06/30/2019 Institution Account(s): TD Health Sciences Fund Page 4 of 94 Express Scripts Holding Co. Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 1 Approve Merger Agreement Mgmt Yes For For No 2 Adjourn Meeting Mgmt Yes For Against Yes 3 Advisory Vote on Golden Parachutes Mgmt Yes For Against Yes Myovant Sciences Ltd. Meeting Date: 08/31/2018 Country: Bermuda Primary Security ID: G637AM102 Record Date: 07/02/2018 Meeting Type: Annual Ticker: MYOV Primary CUSIP: N/A Primary ISIN: BMG637AM1024 Primary SEDOL: BD3WG49 Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 1A Elect Director Mark Altmeyer Mgmt Yes For For No 1B Elect Director Terrie Curran Mgmt Yes For For No 1C Elect Director Mark Guinan Mgmt Yes For For No 1D Elect Director Keith Manchester Mgmt Yes For Against Yes 1E Elect Director Vivek Ramaswamy Mgmt Yes For For No 1F Elect Director Kathleen Sebelius Mgmt Yes For For No 1G Elect Director Lynn Seely Mgmt Yes For For No 2 Approve Ernst & Young LLP Auditors and Mgmt Yes For For No Authorize Board to Fix Their Remuneration Array BioPharma, Inc. Meeting Date: 10/25/2018 Country: USA Primary Security ID: 04269X105 Record Date: 08/29/2018 Meeting Type: Annual Ticker: ARRY Primary CUSIP: 04269X105 Primary ISIN: US04269X1054 Primary SEDOL: 2678654 Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 1a Elect Director Charles M. Baum Mgmt Yes For For No 1b Elect Director Gwen A. Fyfe Mgmt Yes For For No Vote Summary Report Reporting Period: 07/01/2018 to 06/30/2019 Institution Account(s): TD Health Sciences Fund Page 5 of 94 Array BioPharma, Inc. Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 2 Increase Authorized Common Stock Mgmt Yes For For No 3 Advisory Vote to Ratify Named Executive Mgmt Yes For For No Officers' Compensation 4 Ratify KPMG LLP as Auditors Mgmt Yes For For No Ascendis Pharma A/S Meeting Date: 11/02/2018 Country: Denmark Primary Security ID: 04351P101 Record Date: 10/03/2018 Meeting Type: Special Ticker: ASND Primary CUSIP: 04351P101 Primary ISIN: US04351P1012 Primary SEDOL: BV9G6B8 Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt Meeting for ADR Holders Mgmt No 1 Elect Chairman of Meeting Mgmt Yes For For No 2 Elect Lars Holtug as New Director Mgmt Yes For For No 3 Authorize Editorial Changes to Adopted Mgmt Yes For For No Resolutions in Connection with Registration with Danish Authorities Abcam Plc Meeting Date: 11/06/2018 Country: United Kingdom Primary Security ID: G0060R118 Record Date: 11/02/2018 Meeting Type: Annual Ticker: ABC Primary CUSIP: G0060R118 Primary ISIN: GB00B6774699 Primary SEDOL: B677469 Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 1 Accept Financial Statements and Statutory Mgmt Yes For For No Reports 2 Approve Final Dividend Mgmt Yes For For No 3 Approve Remuneration Report Mgmt Yes For For No 4 Approve Remuneration Policy Mgmt Yes For For No 5 Amend 2015 Share Option Plan Mgmt Yes For For No 6 Reappoint PricewaterhouseCoopers LLP as Mgmt Yes For For No Auditors Vote Summary Report Reporting Period: 07/01/2018 to 06/30/2019 Institution Account(s): TD Health Sciences Fund Page 6 of 94 Abcam Plc Vote Proposal Votable Vote Against Number Proposal Text Proponent Proposal Mgmt Rec Instruction Mgmt 7 Authorise the Audit and Risk Committee to Fix Mgmt Yes For ForNo Remuneration of Auditors 8 Elect Peter Allen as Director Mgmt Yes For For No 9 Re-elect Jonathan Milner as Director Mgmt Yes For For No 10 Re-elect Alan Hirzel as Director Mgmt Yes For For No 11 Re-elect Gavin Wood as Director Mgmt Yes For For No 12 Re-elect Louise Patten as Director Mgmt Yes For For No 13 Re-elect Sue Harris as Director Mgmt Yes For For No 14 Re-elect Mara Aspinall as Director Mgmt Yes For For No 15 Authorise Issue of Equity with Pre-emptive Mgmt Yes For For

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    94 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us